Labcorp previously announced the following record and distribution dates for its spin-off of Fortrea Holdings Inc., a wholly owned subsidiary of Labcorp. Fortrea will hold Labcorp’s Clinical Development and Commercialization Services business. The spin-off is expected to be effected through the distribution of 100% of the common stock of Fortrea to holders of Labcorp’s common stock whereby Labcorp’s stockholders will receive one share of Fortrea common stock for every share of Labcorp common stock they hold as of the record date. Labcorp expects that a “when-issued” public trading market for Fortrea’s common stock will begin on or around June 16, 2023, under the symbol “FTREV,” and will continue through the distribution date. Labcorp also anticipates that “regular-way” trading of Fortrea’s common stock will begin on July 3, 2023, the first trading day following the distribution date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on LH:
- 3 Best Stocks to Buy Now, 5/16/2023, According to Top Analysts
- Labcorp and Providence Expand Strategic Laboratory Relationship
- Labcorp enters pact to enter relationship with Jefferson Health
- Labcorp price target lowered to $275 from $285 at Truist
- Labcorp price target lowered to $240 from $265 at Deutsche Bank